Canada · Delayed Price · Currency is CAD Appili Therapeutics Statistics
Total Valuation
TSX:APLI has a market cap or net worth of CAD 1.99 million. The enterprise value is 14.23 million.
| Market Cap | 1.99M |
| Enterprise Value | 14.23M |
Important Dates
The next estimated earnings date is Thursday, July 2, 2026.
| Earnings Date | Jul 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:APLI has 132.37 million shares outstanding. The number of shares has increased by 4.39% in one year.
| Current Share Class | 132.37M |
| Shares Outstanding | 132.37M |
| Shares Change (YoY) | +4.39% |
| Shares Change (QoQ) | +5.85% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | n/a |
| Float | 117.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.13 |
| PB Ratio | -0.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 58.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -162.92% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 39.16% |
| Weighted Average Cost of Capital (WACC) | 5.76% |
| Revenue Per Employee | 34,883 |
| Profits Per Employee | -605,820 |
| Employee Count | 7 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TSX:APLI has paid 105,352 in taxes.
| Income Tax | 105,352 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.23 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 46.22 |
| Average Volume (20 Days) | 61,204 |
Short Selling Information
The latest short interest is 12,229, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 12,229 |
| Short Previous Month | 47,047 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:APLI had revenue of CAD 244,179 and -4.24 million in losses. Loss per share was -0.03.
| Revenue | 244,179 |
| Gross Profit | 244,179 |
| Operating Income | -6.52M |
| Pretax Income | -4.14M |
| Net Income | -4.24M |
| EBITDA | -6.52M |
| EBIT | -6.52M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 40,003 in cash and 12.94 million in debt, with a net cash position of -12.90 million or -0.10 per share.
| Cash & Cash Equivalents | 40,003 |
| Total Debt | 12.94M |
| Net Cash | -12.90M |
| Net Cash Per Share | -0.10 |
| Equity (Book Value) | -17.33M |
| Book Value Per Share | -0.16 |
| Working Capital | -16.67M |
Cash Flow
| Operating Cash Flow | -1.34M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 10,068 |
| Net Borrowing | -104,810 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,672.16% |
| Pretax Margin | -1,693.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:APLI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.39% |
| Shareholder Yield | -4.39% |
| Earnings Yield | -213.59% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |